Books about Cost benefit from Amazon.com

For courses in Cost-Benefit Analysis, taught in Economics Departments, Public Policy Departments, and Public Administration Departments. Also ideal forpracticing policy analysts andpublic managers.This authoritative, market leading book is distinct for it's consistent application of a nine-step framework for conducting or interpreting a cost-benefit analysis.

.
Price: $68.00 [Notify me when price goes down.]

This second edition of Cost Effectiveness Analysis in Health reviews issues and methods of assessing health care technologies and related programs. It emphasizes methods to perform economic evaluations, such as cost-effectiveness and cost-benefit analysis; methods to assess efficacy, effectiveness, and safety of health care technologies; effectiveness research; and applications to clinical and public policy. The book provides in-depth discussion of the uses and conducting of cost-effectiveness analyses (CEAs) as decision-making aids in public health, health services, and medicine. It explores cost-effectiveness in the context of societal decision making for resource allocation purposes. Chapter topics include: Defining and explaining cost-effectiveness, principles of cost-effectiveness analysis, how to develop a research project, working with costs, probabilities and models, calculating life expectancy, working with health-related quality of life measures, calculating quality-adjusted life years, conducting a sensitivity analysis, preparing your study for publication, working with data, and finding the data you need..
Price: $60.80 [Notify me when price goes down.]

Throughout the text of this introduction to benefit cost analysis, emphasis is on applications, and a worked case study is progressively undertaken as an illustration of the analytical principles in operation. The first part covers basic theory and procedures. Part Two advances to material on internationally tradeable goods and projects that affect market prices, and part Three introduces special topics such as the treatment of risk and uncertainty, income distributional effects and the valuation of non-marketed goods. Instructors' resource web site: http://www.uq.edu.au/economics/bca.
Price: $32.92 [Notify me when price goes down.]

A unique, in-depth discussion of the uses and conduct of cost-effectiveness analyses (CEAs) as decision-making aids in the health and medical fields, this volume is the product of over two years of comprehensive research and deliberation by a multi-disciplinary panel of economists, ethicists, psychometricians, and clinicians. Exploring cost-effectiveness in the context of societal decision-making for resource allocation purposes, this volume proposes that analysts include a "reference-case" analysis in all CEAs designed to inform resource allocation and puts forth the most explicit set of guidelines (together with their rationale) ever defined on the conduct of CEAs. Important theoretical and practical issues encountered in measuring costs and effectiveness, evaluating outcomes, discounting, and dealing with uncertainty are examined in separate chapters. Additional chapters on framing and reporting of CEAs elucidate the purpose of the analysis and the effective communication of its findings. Cost-Effectiveness in Health and Medicine differs from the available literature in several key aspects. Most importantly, it represents a consensus on standard methods--a feature integral to a CEA, whose principal goal is to permit comparisons of the costs and health outcomes of alternative ways of improving health. The detailed level at which the discussion is offered is another major distinction of this book, since guidelines in journal literature and in CEA-related books tend to be rather general--to the extent that the analyst is left with little guidance on specific matters. The focused overview of the theoretical background underlying areas of controversy and of methodological alternatives, and, finally, the accessible writing style make this volume a top choice on the reading lists of analysts in medicine and public health who wish to improve practice and comparability of CEAs. The book will also appeal to decision-makers in government, managed care, and industry who wish to consider the uses and limitations of CEAs..
Price: $43.90 [Notify me when price goes down.]

The world has many pressing problems. Thanks to the efforts of governments, NGOs, and individual activists there is no shortage of ideas for resolving them. However, even if all governments were willing to spend more money on solving the problems, we cannot do it all at once. We have to prioritize; and in order to do this we need a better sense of the costs and benefits of each 'solution'. This book offers a rigorous overview of twenty-three of the world's biggest problems relating to the environment, governance, economics, and health and population. Leading economists provide a short survey of the state-of-the-art analysis and sketch out policy solutions for which they provide cost-benefit ratios. A unique feature is the provision of freely downloadable software which allows readers to make their own cost-benefit calculations for spending money to make the world a better place..
Price: $11.45 [Notify me when price goes down.]

Profiteeering pharmaceutical companies and the FDA have met their match in Dr. Jerry Avorn, a Harvard Medical school researcher and clinician. In Powerful Medicines, he brilliantly combines patient vignettes, scientific critique, and statistics to create a risk/benefit balance for prescription drugs. His premise: "Every drug is a triangle with three faces--representing the healing it can bring, the hazards it can inflict and the economic impact of each." Avorn's gifts as a writer are apparent in the prologue, an edgy account of the mismanaged medications of several stroke patients. He then details the intellectual history of drug assessment and benefits, including the biblical food police in the Book of Daniel, the deer in the headlights Estrogen debacle and the current infatuation with Ginseng and other alternative medicines. Turning from benefits to risks, Avorn examines diet pills, Viagra, cold medicines and diabetes drugs with comparisons the decisions of Dr. Fautus--who makes life-changing bargains between safety and effectiveness. Other insightful chapters offer views of prescription drug economies, and comparative healthcare around the globe. The final chapters create an insightful template for emerging public policy. Throughout, Avorn pulls at common threads: the line between personal and public responsibility, the perils of drug promotion, and the marketplace that usurps the role of scientific evidence in selecting treatments. Anyone looking for a quick muckraking read will be disappointed. But Avorn's views, literate and complex, will frame the debate on prescription drugs for years to come. --Barbara Mackoff.
Price: $6.44 [Notify me when price goes down.]

What drug provides Americans with the greatest pleasure and the greatest pain? The answer, hands down, is alcohol. The pain comes not only from drunk driving and lost lives but also addiction, family strife, crime, violence, poor health, and squandered human potential. Young and old, drinkers and abstainers alike, all are affected. Every American is paying for alcohol abuse.

Paying the Tab, the first comprehensive analysis of this complex policy issue, calls for broadening our approach to curbing destructive drinking. Over the last few decades, efforts to reduce the societal costs--curbing youth drinking and cracking down on drunk driving--have been somewhat effective, but woefully incomplete. In fact, American policymakers have ignored the influence of the supply side of the equation. Beer and liquor are far cheaper and more readily available today than in the 1950s and 1960s.

Philip Cook's well-researched and engaging account chronicles the history of our attempts to "legislate morality," the overlooked lessons from Prohibition, and the rise of Alcoholics Anonymous. He provides a thorough account of the scientific evidence that has accumulated over the last twenty-five years of economic and public-health research, which demonstrates that higher alcohol excise taxes and other supply restrictions are effective and underutilized policy tools that can cut abuse while preserving the pleasures of moderate consumption. Paying the Tab makes a powerful case for a policy course correction. Alcohol is too cheap, and it's costing all of us.

.
Price: $29.02 [Notify me when price goes down.]

The story of one African American woman's decision to undergo gastric bypass surgery..
Price: $8.11 [Notify me when price goes down.]

Most organizations spend less than 1% of their training budgets on measurement and evaluation, and this figure only covers post-program analysis. Yet to truly maximize the benefits of ROI, training and performance improvement programs should be measured throughout the planning and development process.

But before jumping on the ROI "bandwagon," you should first determine whether your organization is a candidate for ROI and also how to overcome the various barriers to ROI implementation. In The Bottomline on ROI, Patricia Phillips addresses these critical issues and more..
Price: $11.02 [Notify me when price goes down.]